Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.6 USD | -0.47% | +1.26% | -20.48% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.48% | 19.26B | |
+24.22% | 46.71B | |
+48.83% | 41.8B | |
-0.95% | 41.52B | |
-5.86% | 29.55B | |
+11.11% | 25.78B | |
+2.75% | 12.14B | |
-3.22% | 12.08B | |
+30.44% | 11.98B | |
+20.48% | 11.58B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Chardan Cuts Price Target on Alnylam Pharmaceuticals to $225 From $250, Expects Topline Results in Mid-2024, Maintains Buy Rating